Plus Therapeutics Inc (PSTV)

Plus Therapeutics Inc Aktie (PSTV) Neueste Nachrichten

Plus Therapeutics (NASDAQ:PSTV) vs. Atrion (NASDAQ:ATRI) Financial Contrast - Defense World

Defense World

Stromal Vascular Fraction Market to Witness Robust Expansion by 2031 - openPR

openPR

Stromal Vascular Fraction Market to Witness Robust Expansion by 2031 - openPR

openPR

Plus Therapeutics Announces New Employment Inducement Grants - ForexTV.com

ForexTV.com

Plus Therapeutics Announces New Employment Inducement Grants - GlobeNewswire

GlobeNewswire

Plus Therapeutics Announces New Employment Inducement Grants - Yahoo Finance

Yahoo Finance

Plus Therapeutics Announces New Employment Inducement Grants - Yahoo Finance

Yahoo Finance

Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress - Investing.com India

Investing.com India

Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress By Investing.com - Investing.com

Investing.com

Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress By Investing.com - Investing.com

Investing.com

Plus: Q1 Earnings Snapshot - The Washington Post - The Washington Post

The Washington Post

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

GlobeNewswire

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance

Yahoo Finance

Plus Therapeutics, Inc. (PSTV) Q1 2024 Earnings Call Transcript - Seeking Alpha

Seeking Alpha

Colorectal Cancer Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies ... - openPR

openPR

Plus Therapeutics, Inc. (NASDAQ:PSTV) CEO Marc H. Hedrick Purchases 12255 Shares - Defense World

Defense World

Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024 - GlobeNewswire

GlobeNewswire

Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024 - Yahoo Canada Finance

Yahoo Canada Finance

Plus Therapeutics, Inc. (NASDAQ:PSTV) CEO Marc H. Hedrick Purchases 12255 Shares - Defense World

Defense World

Lenk Robert P buys $8.5k in Plus Therapeutics shares - Investing.com South Africa

Investing.com South Africa

Plus Therapeutics director buys $10,000 in stock By Investing.com - Investing.com

Investing.com

Lenk Robert P buys $8.5k in Plus Therapeutics shares - Investing.com India

Investing.com India

Lenk Robert P buys $8.5k in Plus Therapeutics shares - Investing.com

Investing.com

Plus Therapeutics CFO acquires $10,000 in company stock By Investing.com - Investing.com

Investing.com

Plus Therapeutics director purchases $25,000 in company stock By Investing.com - Investing.com

Investing.com

Plus Therapeutics CFO acquires $10,000 in company stock By Investing.com - Investing.com

Investing.com

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial ... - GlobeNewswire

GlobeNewswire

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial

GlobeNewswire Inc.

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial - ForexTV.com

ForexTV.com

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial

GlobeNewswire Inc.

Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical ... - Yahoo Finance

Yahoo Finance

Plus Therapeutics secures $18 million in financing deal By Investing.com - Investing.com Australia

Investing.com Australia

Plus Therapeutics secures $18 million in financing deal By Investing.com - Investing.com

Investing.com

Plus Therapeutics secures $18 million in financing deal By Investing.com - Investing.com

Investing.com

Plus Therapeutics Announces Private Placement Financing of up to $18 Million - GlobeNewswire

GlobeNewswire

Plus Therapeutics Announces Private Placement Financing of up to $18 Million

GlobeNewswire Inc.

Plus Therapeutics Announces Private Placement Financing of up to $18 Million - GlobeNewswire

GlobeNewswire

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus ... - Business Wire

Business Wire

Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense - GlobeNewswire

GlobeNewswire

Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus' Management Team - GlobeNewswire

GlobeNewswire

CAN-2409 Plus Valacyclovir Generates Positive Phase 2 Survival Results in PDAC - OncLive

OncLive

Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates

Zacks Investment Research

Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference - GlobeNewswire

GlobeNewswire

Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic - Yahoo Finance

Yahoo Finance

Virtual Event Benzinga Virtual Healthcare Summit 2024 - Benzinga

Benzinga

Flagship Pioneering is one of Fast Company's Most Innovative Companies - Fast Company

Fast Company

Plus Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India

Investing.com India

Plus Therapeutics CEO's Insightful Presentation Now Available - TipRanks.com - TipRanks

TipRanks

Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in ... - GlobeNewswire

GlobeNewswire

Plus Therapeutics Full Year 2023 Earnings: Beats Expectations - Yahoo Finance

Yahoo Finance